SCHEMBL17037347

SCHEMBL17037347

N#Cc1ccc(-c2nc3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc3c3c2ccc2ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 10/20 0.44
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C19 P33261 2/20 0.42
CLK4 Q9HAZ1 2/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
ABCB1 P08183 5/20 0.41
ATM Q13315 1/20 0.41
MAPK1 P28482 1/20 0.40
ADORA2A P29274 1/20 0.39
KDM4E B2RXH2 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034939 0.93 CYP1A2 (0.42) ABCG2MEN1KMT2AALDH1A1CYP1A2
SCHEMBL17035030 0.90 MEN1 (0.49) MEN1KMT2AALDH1A1CYP1A2LMNA
SCHEMBL17037284 0.89 ABCG2 (0.45) ABCG2MEN1KMT2AALDH1A1CYP1A2
SCHEMBL17037262 0.88 MEN1 (0.45) ABCG2MEN1KMT2AALDH1A1LMNA
SCHEMBL17035152 0.87 ABCG2 (0.43) ABCG2MEN1KMT2AALDH1A1CYP1A2
SCHEMBL17035072 0.87 MEN1 (0.46) MEN1KMT2AALDH1A1CYP1A2CYP3A4
SCHEMBL17035068 0.86 MEN1 (0.48) MEN1KMT2AALDH1A1LMNAATM
SCHEMBL17302716 0.86 ABCG2 (0.45) ABCG2MEN1KMT2AALDH1A1CYP1A2
SCHEMBL17035069 0.84 MEN1 (0.44) MEN1KMT2AALDH1A1LMNAATM
SCHEMBL17034886 0.84 MEN1 (0.56) ABCG2MEN1KMT2ALMNAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ABCG2 4363/4885MEN1 476/4885KMT2A 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.